Reset all filters
01 1Agomelatine
02 6Indapamida; Perindopril Erbumina
03 2Indapamide; Perindopril Terc-Butylamine
04 2Ivabradinhydroklorid
Reset all filters
01 3Film Coated Tablet
02 8Tablet
Reset all filters
01 125mg
02 44MG; 1.25 MG
03 15mg
04 17.5mg
05 48MG; 2.5 MG
Reset all filters
01 8Spain
02 3Sweden
Reset all filters
01 1Agomelatine Anpharm
02 8Bipreterax
03 2Ivabradine Anpharm
Regulatory Info : Deregistered
Registration Country : Sweden
Dosage Form : Film Coated Tablet
Dosage Strength : 25mg
Packaging :
Brand Name : Agomelatine Anpharm
Approval Date : 28/09/2018
Application Number : 20170703000110
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Film Coated Tablet
Dosage Strength : 5mg
Packaging :
Brand Name : Ivabradine Anpharm
Approval Date : 08/09/2015
Application Number : 20150524000018
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Authorized
Registration Country : Spain
Indapamide; Perindopril Terc-Butylamine
Dosage Form : Tablet
Dosage Strength : 4MG; 1.25 MG
Packaging :
Brand Name : Bipreterax
Approval Date : 2023-10-10
Application Number : OGYI-T-6831-01IP2
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Indapamide; Perindopril Terc-Butylamine
Dosage Form : Tablet
Dosage Strength : 4MG; 1.25 MG
Packaging :
Brand Name : Bipreterax
Approval Date : 2024-07-26
Application Number : OGYI-T-6831-01IP3
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Indapamida; Perindopril Erbumina
Dosage Form : Tablet
Dosage Strength : 4MG; 1.25 MG
Packaging :
Brand Name : Bipreterax
Approval Date : 2021-12-15
Application Number : OGYI-T-6831-01IP1
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Indapamida; Perindopril Erbumina
Dosage Form : Tablet
Dosage Strength : 8MG; 2.5 MG
Packaging :
Brand Name : Bipreterax
Approval Date : 2023-10-27
Application Number : OGYI-T-6831-02IP2
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Indapamida; Perindopril Erbumina
Dosage Form : Tablet
Dosage Strength : 8MG; 2.5 MG
Packaging :
Brand Name : Bipreterax
Approval Date : 2020-04-16
Application Number : OGYI-T-6831-02
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Indapamida; Perindopril Erbumina
Dosage Form : Tablet
Dosage Strength : 8MG; 2.5 MG
Packaging :
Brand Name : Bipreterax
Approval Date : 2022-10-24
Application Number : OGYI-T-6831-02IP1
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Indapamida; Perindopril Erbumina
Dosage Form : Tablet
Dosage Strength : 4MG; 1.25 MG
Packaging :
Brand Name : Bipreterax
Approval Date : 2020-04-03
Application Number : OGYI-T-6831-01
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Indapamida; Perindopril Erbumina
Dosage Form : Tablet
Dosage Strength : 8MG; 2.5 MG
Packaging :
Brand Name : Bipreterax
Approval Date : 2021-12-15
Application Number : OGYI-T-6831-02IP
Regulatory Info : Authorized
Registration Country : Spain